Answering patient-centred questions efficiently: response-adaptive platform trials in primary care

Affiliations

¹ Primary Care Clinical Trials Unit, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
² ConfluenceStat, LLC; University of Central Florida College of Medicine, Orlando Florida, US.
³ Department of Emergency Medicine, Harbor-UCLA Medical Center; Senior Medical Scientist, Berry Consultants, LLC, Austin, Texas, US.
⁴ Berry Consultants, LLC, Austin, Texas, US.
⁵ Berry Consultants, LLC, Austin, Texas; Adjunct Assistant Professor, Vanderbilt University School of Medicine, US.
⁶ Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.

Christopher C Butler et al. Br J Gen Pract. 2018 Jun.

. 2018 Jun;68(671):294-295.

doi: 10.3399/bjgp18X696569.

¹ Primary Care Clinical Trials Unit, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
² ConfluenceStat, LLC; University of Central Florida College of Medicine, Orlando Florida, US.
³ Department of Emergency Medicine, Harbor-UCLA Medical Center; Senior Medical Scientist, Berry Consultants, LLC, Austin, Texas, US.
⁴ Berry Consultants, LLC, Austin, Texas, US.
⁵ Berry Consultants, LLC, Austin, Texas; Adjunct Assistant Professor, Vanderbilt University School of Medicine, US.
⁶ Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.

No abstract available

References

1. Herbst RS, Gandara DR, Hirsch FR, et al. Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400. Clin Cancer Res. 2015;21(7):1514–1524. - PMC - PubMed
1. Alexander BM, Wen PY, Trippa L, et al. Biomarker-based adaptive trials for patients with glioblastoma — lessons from I-SPY 2. Neuro Oncol. 2013;15(8):972–978. - PMC - PubMed
1. Berry SM, Connor JT, Lewis RJ. The platform trial: an efficient strategy for evaluating multiple treatments. JAMA. 2015;313(16):1619–1620. - PubMed
1. Saville BR, Berry SM. Efficiencies of platform clinical trials: a vision of the future. Clin Trials. 2016;13(3):358–366. - PubMed
1. Connor JT, Elm JJ, Broglio KR, ESETT and ADAPT-IT Investigators Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus. J Clin Epidemiol. 2013;66(8 Suppl):S130–S137. - PMC - PubMed